Apellis Pharmaceuticals, Inc. financial data

Symbol
APLS on Nasdaq
Location
100 Fifth Avenue, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 387 % -2.72%
Quick Ratio 48.3 % -31.6%
Debt-to-equity 276 % +7.8%
Return On Equity 18.9 %
Return On Assets 5.04 %
Operating Margin 7.91 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127M shares +1.71%
Common Stock, Shares, Outstanding 127M shares +3.63%
Entity Public Float 4.2B USD -60.7%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 126M shares +1.76%
Weighted Average Number of Shares Outstanding, Diluted 130M shares +4.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.02B USD +42.1%
Research and Development Expense 298M USD -7.03%
General and Administrative Expense 501M USD +80.7%
Operating Income (Loss) 80.4M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 46.7M USD
Income Tax Expense (Benefit) 1.7M USD -26.3%
Net Income (Loss) Attributable to Parent 45M USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 479M USD +20.7%
Accounts Receivable, after Allowance for Credit Loss, Current 346M USD +23.8%
Inventory, Net 123M USD +1.46%
Other Assets, Current 10.2M USD -13.8%
Assets, Current 991M USD +18.8%
Property, Plant and Equipment, Net 1.93M USD -43%
Operating Lease, Right-of-Use Asset 19.7M USD +15.6%
Other Assets, Noncurrent 5.49M USD +279%
Assets 1.06B USD +17.4%
Accounts Payable, Current 38.6M USD -9.66%
Accrued Liabilities, Current 140M USD +0.35%
Liabilities, Current 280M USD +46.2%
Operating Lease, Liability, Noncurrent 13.7M USD +19.9%
Other Liabilities, Noncurrent 3.26M USD -66.9%
Liabilities 658M USD -1.08%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.4M USD +23.6%
Retained Earnings (Accumulated Deficit) -2.95B USD +1.5%
Stockholders' Equity Attributable to Parent 401M USD +69.2%
Liabilities and Equity 1.06B USD +17.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.4M USD +59.8%
Net Cash Provided by (Used in) Financing Activities 108M USD -72.3%
Net Cash Provided by (Used in) Investing Activities -8K USD +97.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 127M shares +3.63%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -52.8M USD -109%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 481M USD +20.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.1M USD +575%
Deferred Tax Assets, Valuation Allowance 724M USD -3.96%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 726M USD -3.92%
Operating Lease, Liability 17M USD -5.26%
Depreciation 446K USD +0.45%
Payments to Acquire Property, Plant, and Equipment 8K USD -97.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 45.7M USD
Lessee, Operating Lease, Liability, to be Paid 18.3M USD -7.49%
Operating Lease, Liability, Current 7.02M USD +3.39%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.08M USD +13.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.47M USD +1.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -13.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.35M USD -28.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.35M USD -55.6%
Deferred Tax Assets, Operating Loss Carryforwards 313M USD -5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 559K USD -34.9%
Operating Lease, Payments 2.31M USD +14.3%
Additional Paid in Capital 3.36B USD +3.65%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%